Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5583991 | Seminars in Arthritis and Rheumatism | 2017 | 8 Pages |
Abstract
Demographics of the GiACTA population reflect the epidemiologic profile of GCA. Baseline comorbidities associated with glucocorticoids were more prevalent among relapsing patients than among those with newly diagnosed disease, highlighting the need for new GCA treatment options. More than one-third of patients were enrolled based on large-vessel imaging.
Keywords
Polymyalgia rheumaticaESRCTATABevery 2 weeksGCAACRQ2WMRAHbA1cPMRPET/CTGiant cell arteritiscomputed tomographic angiographyMagnetic resonance angiographystandard deviationBiologicalsTemporal artery biopsyPositron emission tomography (PET)positron emission tomography/computed tomographyerythrocyte sedimentation ratetemporal arteryHemoglobin A1cC-reactive proteinCRPClinical trialAmerican College of RheumatologyGlucocorticoids
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Katie PhD, Neil PhD, Sophie MSc, Micki MD, Daniel MD, PhD, Elisabeth MD, PhD, Maria C. MD, Bhaskar MBBS, MD, FRCP, Juergen MD, Carlo MD, Sebastian H. MD, John H. MD, MPH, GiACTA Investigators GiACTA Investigators,